Toxicol Res 4:563575
Cleveland et al (Cleveland, DeLaPaz, Fawwaz, & Challop, 2009) report the case of a young man, with somewhat atypical but quite disabling OCD, whose symptoms improved with high-dose glycine treatment
doi: 10.1002/hipo.23040 84 KozakRCampbellBMStrickCAHornerWHoffmannWEKissTet al
Nacuitys molecules are differentiated, prescription-quality, GMP-grade moieties, which, combined with innovative delivery technologies, are poised to address diseases and conditions involving oxidative stress including retinitis pigmentosa, cataract and cystinosis as well as rare neurological diseases
The composition includes: Grass-fed tallow as structural base Jojoba oil for wax ester stability Squalane for lipid uniformity Rose oil and lavender for formulation consistency Vitamin E as antioxidant stabilizer GHK-Cu peptide integrated within the matrix Historical Background and Scientific Context GHK-Cu was first identified in the 1970s and has since been studied extensively in laboratory environments exploring peptide signalling and molecular interaction pathways
